Latest / Pharmacy Podcast Network / NASP 2024 Annual Meeting LIVE ReCap Show Part One | NASP Specialty Pharmacy Podcast
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:08Speaker 1: to the pharmacy profession. Welcome to the Pharmacy podcast Network.
- 0:24Speaker 2: Welcome back to the Pharmacy podcast Networks coverage of the
- 0:27Speaker 2: NASP twenty twenty four. We're thrilled to be back interviewing
- 0:31Speaker 2: specialty pharmacy leaders with our special four part series covering
- 0:34Speaker 2: the annual meeting and expo held in Nashville from October
- 0:37Speaker 2: sixth through the ninth. As the official press and media
- 0:40Speaker 2: partner for NASP, we're here to bring you the latest
- 0:43Speaker 2: insights and highlights from this important gathering. This year, industry
- 0:47Speaker 2: thought leaders and healthcare veterans from across the nation united
- 0:50Speaker 2: to discuss the future of specialty pharmacy in the evolving
- 0:52Speaker 2: patient journey. So here we go with part one of
- 0:55Speaker 2: our series with support from our sponsor Akaria Hell.
- 0:59Speaker 3: We are here at the NASP twenty twenty four in Nashville,
- 1:03Speaker 3: and we are here with akari A Health, which is
- 1:06Speaker 3: one of our sponsors. We're so appreciative of this opportunity
- 1:11Speaker 3: to talk with this team. I'd like you to all
- 1:14Speaker 3: introduce yourself. We're going to start with Rachel.
- 1:17Speaker 4: Hello, Rachel Wickard, I am clinical account executive at a
- 1:20Speaker 4: Carria Health Specialty Pharmacy.
- 1:23Speaker 5: I am Scott mcnier.
- 1:25Speaker 6: I am vice president of account Management and Pharma Business
- 1:28Speaker 6: Development to carry a health specially pharmacy.
- 1:31Speaker 7: Jill Casalino, vice President of Farmer Services Business Development.
- 1:36Speaker 3: This is an exciting time to be able to come
- 1:38Speaker 3: together and define the next stage of specialty pharmacy.
- 1:43Speaker 5: Scott, I'd like to start out with you.
- 1:45Speaker 3: Can you tell us more about what makes Acari a
- 1:48Speaker 3: health stand out in our industry?
- 1:50Speaker 6: Absolutely so. We're a comprehensive specialty pharmacy. We're servicing all
- 1:57Speaker 6: specialty disease states. We have wholesale distribute operations covering all
- 2:01Speaker 6: fifty states, as well as non commercial free drug programs
- 2:05Speaker 6: servicing all fifty states and US territories.
- 2:09Speaker 5: We have a number of.
- 2:11Speaker 6: Exclusive programs by service. We have over two hundred limited
- 2:15Speaker 6: distribution drugs. We have a fifty plus person field sales
- 2:21Speaker 6: and provider experienced team that services all of our prescribers
- 2:25Speaker 6: across the country. Our niche really is that we're a
- 2:29Speaker 6: top ten specialty pharmacy. We're big enough to be competitive
- 2:33Speaker 6: with the big sps. However, we really approach is really
- 2:37Speaker 6: more of an independent we're trying to build that personalized,
- 2:40Speaker 6: customized service helping to really solve problems in collaboration of
- 2:44Speaker 6: partnership with our clients.
- 2:46Speaker 3: Joe, how does ACARI help plan to further expand or
- 2:51Speaker 3: evolve your services?
- 2:53Speaker 7: You know, out of carry Health, we're continually looking to
- 2:55Speaker 7: innovate and expand our offerings. Our focus is enhanced seeing
- 3:00Speaker 7: our services and areas like gene and rare therapy, as
- 3:04Speaker 7: well as integrating AI technology to refine our quality, monitoring
- 3:08Speaker 7: and improve patient outcomes. We're also investing heavily in digital
- 3:13Speaker 7: solutions such as digital texting initiatives, which aim to streamline
- 3:18Speaker 7: patient engagement and customize our services to better meet the
- 3:22Speaker 7: needs of our patients.
- 3:23Speaker 5: Thank you so much for that, Joe Rachel. You're going
- 3:26Speaker 5: to be.
- 3:26Speaker 3: Presenting two posters here at the NESP twenty twenty four
- 3:30Speaker 3: that focus on the impact of our karia's.
- 3:34Speaker 5: Programs and on patient adherence.
- 3:36Speaker 3: Adherence is so important, especially and specially can you share
- 3:40Speaker 3: some of the insights from your presentations.
- 3:44Speaker 4: Yeah, so we're excited to present this time around, and
- 3:47Speaker 4: what we're looking at is, just as Joe mentioned, we're
- 3:50Speaker 4: trying to look at the impact of these innovations on
- 3:54Speaker 4: specialty pharmacy and impact on patients. So we looked at
- 3:57Speaker 4: two approaches. The first approach just looking at the impact
- 4:01Speaker 4: of these digital refill methods on adherence. So we're looking
- 4:05Speaker 4: at text message and online portal compared to your traditional
- 4:10Speaker 4: telephonic means to refill and really what was that impact
- 4:14Speaker 4: in oncology patients. The other approach that we're looking at
- 4:18Speaker 4: is just an enhanced support of managing these therapies. So
- 4:22Speaker 4: the other posters looking at a nurse led specialty pharmacy
- 4:26Speaker 4: adherence program and what was the impact of that support.
- 4:30Speaker 4: So you have a set standard outreach along with risk ranking,
- 4:33Speaker 4: so it gives you an individualized piece to managing therapy
- 4:38Speaker 4: and that's for patients that were new to penatine therapy.
- 4:41Speaker 4: So overall, the results they you know, demonstrated improvement on
- 4:45Speaker 4: adherence and persistency. We're kind of you know, thinking, you know,
- 4:49Speaker 4: looking forward. We're putting our work into these innovations. How
- 4:54Speaker 4: do we you know, Number one, increase engagement, So as
- 4:58Speaker 4: Joe mentioned, we're looking at ways to improve and drive
- 5:01Speaker 4: that engagement. We see that it's impactful, but we want
- 5:04Speaker 4: to get patients into those methods and then really just
- 5:08Speaker 4: looking at board here and some persistency, what's that next
- 5:11Speaker 4: step and the impact on outcomes overall.
- 5:14Speaker 8: So yeah, es.
- 5:17Speaker 5: Excellent, Thank you, Rachel Scott.
- 5:19Speaker 3: I did want to follow up, can you can you
- 5:22Speaker 3: kind of elaborate on how Akari Health is going to
- 5:24Speaker 3: use technology to improve your patient care?
- 5:27Speaker 6: Absolutely, so you know, not surprisingly, you know technologies core
- 5:31Speaker 6: to how we plan to enhance some patient experience. Right, So,
- 5:35Speaker 6: we have a couple significant investments we're making currently. One
- 5:39Speaker 6: is moving our platform to a cloud based platform, so overall,
- 5:43Speaker 6: it's going to help us with operational efficiencies. It's going
- 5:46Speaker 6: to help us enhance our reporting analytics capabilities as well
- 5:50Speaker 6: as allow us API connectivity to do things that we've
- 5:53Speaker 6: never been able to do in the past. Secondly, just
- 5:56Speaker 6: partnering with innovative vendors. So I think we're looking at
- 5:59Speaker 6: all the different options we have in the industry and
- 6:02Speaker 6: currently actually working on an implementation for digital enhancement product. Primarily,
- 6:10Speaker 6: historically we've done most of our engagement or digital engagement
- 6:15Speaker 6: through a texting program, so refills are actually refill reminders
- 6:20Speaker 6: and actually the ability to refill via text providing medication
- 6:24Speaker 6: education through that channel as well as adherence solutions. So
- 6:28Speaker 6: as a matter of fact, you're to date one third
- 6:31Speaker 6: of our refills have actually come through a digital solution
- 6:34Speaker 6: in our company.
- 6:36Speaker 5: That's incredible.
- 6:37Speaker 3: I know that with this age and how we're using
- 6:40Speaker 3: mobile technology, people are so comfortable texting back questions that
- 6:45Speaker 3: you might have sent them about a specific treatment, where
- 6:48Speaker 3: they are, how they're feeling. Can you tell me more
- 6:51Speaker 3: about the information you're pulling into a pharmacy management system
- 6:55Speaker 3: of some sort?
- 6:56Speaker 5: Does that help or follow up?
- 6:58Speaker 3: Are you seeing an increase in adherence by the type
- 7:00Speaker 3: of the type of in you know, being involved with
- 7:05Speaker 3: them through texting ongoing.
- 7:07Speaker 5: Day to day.
- 7:09Speaker 4: Yeah, I think it really does help to drive that
- 7:11Speaker 4: kind of individualized experience. So the feedback that we get
- 7:16Speaker 4: into there, it might be related to I have a
- 7:18Speaker 4: question about my nest injection, I have questions about my refill,
- 7:23Speaker 4: or I have questions about just the overall regimen in general.
- 7:28Speaker 4: And so I feel like just by having that open
- 7:30Speaker 4: line of communication where patients do feel like they can
- 7:33Speaker 4: you know, respond and have that immediate feedback, it does
- 7:37Speaker 4: add a layer of you know, improving the overall experience
- 7:41Speaker 4: and therefore adherence and persistency for sure, Joe.
- 7:46Speaker 3: Let's shift to the partnership that Akaria has developed with
- 7:50Speaker 3: your manufacturers and how important that is to everything in
- 7:54Speaker 3: the world of specialty pharmacy. So how do you collaborate
- 7:58Speaker 3: with manufacturers to add value?
- 8:00Speaker 7: You know, Actually, collaboration with manufacturers is the cornerstone of
- 8:05Speaker 7: our services. One key area is free drug programs, which
- 8:09Speaker 7: we operate on behalf of the manufacturers. These programs are vital.
- 8:14Speaker 7: They provide critical access to medications for patients we may
- 8:19Speaker 7: not otherwise afford them, offering support from patient assistance and
- 8:23Speaker 7: quick start programs that help bridge gaps in coverage or
- 8:27Speaker 7: financial need. By managing these programs, we ensure patients can
- 8:32Speaker 7: begin and continue therapy without interruptions, reinforcing our commitment to
- 8:37Speaker 7: accessible care and strong manufacturer partnerships.
- 8:42Speaker 5: Thank you, Scott.
- 8:43Speaker 3: I think of the challenges that specially pharmacy goes through
- 8:48Speaker 3: even getting in a network. Then when you finally have
- 8:51Speaker 3: all the infrastructure, the technology, the programs in place, communication
- 8:55Speaker 3: with your patient is so key.
- 8:56Speaker 5: And so important. So what are the biggest.
- 8:59Speaker 3: Operation unities or challenges that is spacing or cari health
- 9:03Speaker 3: right now?
- 9:04Speaker 9: Yeah, I'll start with opportunities.
- 9:06Speaker 6: I think the advanced therapies like gene therapy, we're seeing
- 9:09Speaker 6: significant growth potential there. So you know, within the gene
- 9:13Speaker 6: therapy space, it's just being in that space has made
- 9:16Speaker 6: us a better company overall. We had to implement that
- 9:19Speaker 6: new processes to handle that, a new high touch model
- 9:23Speaker 6: just to be able to manage those patients. As you
- 9:25Speaker 6: can appreciate having a drug as expensive as gene therapy
- 9:29Speaker 6: or therapy as expensive as they are, there's a lot
- 9:31Speaker 6: of tanks within the pharmacy itself, within the payers, with
- 9:35Speaker 6: even in the manufacturers making sure it gets they're appropriately
- 9:37Speaker 6: So it's really made us a better pharmacy.
- 9:40Speaker 9: I'm just doing it.
- 9:40Speaker 6: But in the long term we still see a significant
- 9:43Speaker 6: opportunity for us there. I think in the challenges, it's
- 9:46Speaker 6: really just kind of navigating the regulatory space. So for IRA,
- 9:50Speaker 6: for example, is coming out, the patients really don't understand
- 9:54Speaker 6: the impact that it's going to have on them. So
- 9:56Speaker 6: for us being able to stay out in front of that,
- 9:59Speaker 6: continue to edge date them and engage them in their
- 10:02Speaker 6: therapy to make sure that they stay engaged in inherent
- 10:04Speaker 6: We'll continue to be a challenge for us because as
- 10:09Speaker 6: the primary point of contact with those patients month in
- 10:12Speaker 6: and month out.
- 10:13Speaker 9: We have an opportunity to really help.
- 10:15Speaker 6: With that and keep them engaged. So, you know, I think,
- 10:18Speaker 6: in in closing on that, I think our commitment to
- 10:23Speaker 6: technology and innovation and our commitment to our solving problems
- 10:28Speaker 6: for our clients, adding value for our clients really is
- 10:31Speaker 6: going to help us overcome those challenges though and continue
- 10:33Speaker 6: to leave the industry.
- 10:35Speaker 5: Thank you so much, Rachel.
- 10:37Speaker 3: If someone's listening, they want to engage Akaria Health, what's
- 10:40Speaker 3: the best way.
- 10:41Speaker 5: To reach out to your team?
- 10:43Speaker 4: Yeah, so number one, stopping by our posters here at
- 10:46Speaker 4: an AESP so we can you know, kind of have
- 10:48Speaker 4: some of those engage in conversations. Afterwards, we have our
- 10:52Speaker 4: LinkedIn profiles, We have information for how to reach us
- 10:55Speaker 4: directly through email at a Carre of Health. So please
- 10:58Speaker 4: reach out and please start by the.
- 11:01Speaker 3: Excellent once again we were here with their curR A
- 11:04Speaker 3: Health team here at the NASP. Thank you so much
- 11:07Speaker 3: for sponsoring the NASP podcast and being part.
- 11:10Speaker 5: Of the show.
- 11:11Speaker 6: Thank you, Todd.
- 11:12Speaker 7: Thanks talking.
- 11:16Speaker 3: A leader postel here with Walmart's Specialty at the NASP
- 11:20Speaker 3: twenty twenty four.
- 11:21Speaker 8: Nice to meet you.
- 11:22Speaker 3: Todd, It's nice to see you again. This is almost
- 11:24Speaker 3: becoming a tradition of ours. This is the second year
- 11:28Speaker 3: that you've been able to participate in the post show.
- 11:30Speaker 3: It's important for us to have your type of representation
- 11:34Speaker 3: as well as the mind share of where we are going.
- 11:37Speaker 3: It's together our ex as I always say, hashtag together
- 11:40Speaker 3: our ex Walmart presents a very special opportunity in specialty
- 11:45Speaker 3: pharmacy because obviously there's just this massive reach that you
- 11:49Speaker 3: have into communities that are desperate from war pharmacy care.
- 11:52Speaker 3: Not less so when we start thinking of disease states
- 11:55Speaker 3: and conditions and anything that might be within the community,
- 11:58Speaker 3: there's a lot of head scratch from them where they're like,
- 12:01Speaker 3: all right, I use my Walmart pharmacy, but what could
- 12:05Speaker 3: I get if I needed extra care for my child
- 12:07Speaker 3: or myself. Talk to us about expansion of specialty in
- 12:10Speaker 3: community through Walmart.
- 12:12Speaker 8: Absolutely, so when you think about Walmart, right the people
- 12:15Speaker 8: are going there for their everyday needs. We talked about
- 12:17Speaker 8: that last time. It is in your community. We have
- 12:20Speaker 8: ninety percent of Americans live within ten miles of a Walmart,
- 12:23Speaker 8: and so knowing where we sit, knowing our footprint, the
- 12:27Speaker 8: next expansion from US, and the last time we talked
- 12:29Speaker 8: was autoimmune. Autommune patient. They have nutrition needs OTCS, over
- 12:33Speaker 8: the counter medications. There are a number of supple supplements
- 12:36Speaker 8: that they also need for their care. So when we
- 12:39Speaker 8: thought about where we wanted to be and how can
- 12:41Speaker 8: we make it easy. A lot of our autommune patients
- 12:44Speaker 8: their caregivers right their mothers, they're the head of their families,
- 12:48Speaker 8: and so we wanted to simplify the process and allow
- 12:50Speaker 8: us to be able to come to them, meet them
- 12:52Speaker 8: where they are right. So as we expanded our autommune
- 12:55Speaker 8: community pharmacies, it was really important that we were intentional
- 12:58Speaker 8: on where we put them, but also create an ease
- 13:01Speaker 8: for them to be able to utilize our services. So
- 13:03Speaker 8: I'm really excited because we've expanded to thirty one locations.
- 13:06Speaker 8: We now have over one hundred and thirty eight community
- 13:09Speaker 8: pharmacies across the US, and we're servicing both HIV, which
- 13:13Speaker 8: was our initial expansion and now we have leaned into autoimmune.
- 13:16Speaker 5: It's incredible, it's incredible.
- 13:18Speaker 3: So what other partnerships is Walmart Specialty forming in order
- 13:23Speaker 3: to grow out that specialty and autoimmune?
- 13:26Speaker 8: So simple answer, right, Our manufacturer partners are always important
- 13:30Speaker 8: for us making sure that we have access to those
- 13:32Speaker 8: key therapies in our community pharmacies. But then also the
- 13:36Speaker 8: right community advocates right who we partner with in those
- 13:39Speaker 8: communities and let them know that we're there and that
- 13:41Speaker 8: we can help service the patients. And so we're doing
- 13:44Speaker 8: a number of community activations as well, so you'll hear
- 13:46Speaker 8: more about that, especially toward the end of the year,
- 13:49Speaker 8: where we're getting together with community partners and looking at
- 13:52Speaker 8: especially think about this. You know, the laws are changing
- 13:54Speaker 8: as far as the practice of pharmacy, you know that, right,
- 13:58Speaker 8: and so as these laws change, as things kind of evolve,
- 14:01Speaker 8: what we're wanting to do is be there right when
- 14:04Speaker 8: it happens and have the right conversation on implementation strategies
- 14:08Speaker 8: are if we know that there's an area that we
- 14:10Speaker 8: need to lean into, what is that call to action
- 14:12Speaker 8: that we should have. So you'll see more of that
- 14:13Speaker 8: from us as we continue to expand our offerings Alida.
- 14:17Speaker 3: The health system throughout different communities throughout the United States
- 14:21Speaker 3: is very focused.
- 14:22Speaker 5: A lot of them are very focused on specialty.
- 14:24Speaker 3: How would Walmart's specialty align and parallel with them to
- 14:29Speaker 3: let them know, Hey, if you wanted our support with
- 14:32Speaker 3: our reach, that you could start engaging with health.
- 14:35Speaker 5: Systems as well.
- 14:36Speaker 8: Yeah. So one of the things to we want to
- 14:39Speaker 8: dispel is that we're not here to take the place
- 14:41Speaker 8: of your provider. That is such an important relationship, right.
- 14:45Speaker 8: We see ourselves as an extension of that care continuum,
- 14:48Speaker 8: and so partnering with the health systems providing the services
- 14:51Speaker 8: that you may not be able to get to within
- 14:53Speaker 8: our pharmacy. So we have immunizations, we have tests and
- 14:56Speaker 8: treat Sometimes you don't want to burden the health system
- 14:58Speaker 8: with that, right, and so we've done more with our
- 15:00Speaker 8: test to treat programs where we're testing for flu, strep,
- 15:04Speaker 8: COVID and so those are the things that we want
- 15:06Speaker 8: to be able to offer as an extension of that.
- 15:08Speaker 8: And a lot of times too, it is the convenience
- 15:11Speaker 8: factor too. Is being able to get to a Walmart.
- 15:12Speaker 8: We're open on the weekends, we're open later in the evenings,
- 15:16Speaker 8: so being able to come and get those services is
- 15:18Speaker 8: something we want to also be able to provide and
- 15:20Speaker 8: let these our communities know that we are there. We
- 15:22Speaker 8: also offer our Wellness Days, which happens four times a
- 15:26Speaker 8: year and so we have big campaigns where you can
- 15:28Speaker 8: come in and get free screenings from our pharmacy teams
- 15:32Speaker 8: and understand the offerings that we have within our pharmacy.
- 15:35Speaker 8: So that's another way that we're working and partnering with
- 15:37Speaker 8: systems and communities to let them know that they're available
- 15:39Speaker 8: services within our pharmacies.
- 15:41Speaker 3: Alita, are you focused on any additional treatment disease state
- 15:45Speaker 3: conditions for twenty twenty five?
- 15:47Speaker 8: We will be. I will announce that soon. But we
- 15:50Speaker 8: are definitely leaning in and doing some really unique things
- 15:52Speaker 8: and we're just exploring options right it has to make
- 15:55Speaker 8: sense as well, but we are also looking at where
- 15:57Speaker 8: can we deliver care? Where do we go next? Always
- 16:00Speaker 8: in the forefront of how we're thinking, and then looking
- 16:03Speaker 8: at our footprint, where's the best place for us to
- 16:05Speaker 8: put our community pharmacies.
- 16:07Speaker 3: Alida, as a woman of color, how is your representation
- 16:12Speaker 3: in what you've done and how vocal you've been?
- 16:15Speaker 5: I watch you on LinkedIn. I cheer you on as
- 16:17Speaker 5: much as we can.
- 16:19Speaker 3: There are people watching you, young pharmacists, even people that
- 16:23Speaker 3: are deciding that they're in biology, maybe they're going to
- 16:25Speaker 3: go into pharmacy. What kind of responsibility do you have
- 16:29Speaker 3: to kind of set a precedence, a pathway for women
- 16:34Speaker 3: to lead in healthcare.
- 16:35Speaker 8: So my journey into healthcare started by accident. Right, I
- 16:40Speaker 8: didn't know that I wanted to be in healthcare. There
- 16:42Speaker 8: was a period that I wanted to be a law
- 16:45Speaker 8: enforcement officer and I went through that and the reason
- 16:48Speaker 8: why I wanted to help people, right and from the
- 16:50Speaker 8: communities that I come from. Sometimes being in health care
- 16:54Speaker 8: is not always been trusted. Right, But when you see
- 16:58Speaker 8: someone that looks like me, I'm able to educate my family,
- 17:02Speaker 8: educate my friends, educate my friends on what you should
- 17:05Speaker 8: be doing. Preventive care especially, it's a big deal, right.
- 17:09Speaker 8: And I'll take the case of COVID. When I told
- 17:12Speaker 8: family members that I was working at Walmart and that
- 17:15Speaker 8: we were delivering immunizations for COVID, there was a lot
- 17:18Speaker 8: of hesitancy and trust issues, right, But being able to say, hey,
- 17:22Speaker 8: I've done it, I've safely taken it, my family has
- 17:24Speaker 8: safely taken it. Here's what you should know, here's what
- 17:27Speaker 8: I'm hearing. Here's the impact in our community. Because in
- 17:30Speaker 8: African American communities, autoimmune is a big deal, right, asthma
- 17:34Speaker 8: a big deal, and you get COVID or you get sick.
- 17:37Speaker 8: It was impactful. So being able to tie that I
- 17:39Speaker 8: suffer from asthma and I know what it was like
- 17:41Speaker 8: when I had COVID. It was not easy for me.
- 17:44Speaker 8: So being able to use my personal experience to resonate
- 17:46Speaker 8: with them, but especially being a person of color and
- 17:49Speaker 8: being able to speak to others, I do feel like
- 17:52Speaker 8: I have a duty to make sure that they understand
- 17:54Speaker 8: and they know what's available. But then also it's education right,
- 17:58Speaker 8: being able to speak in a way that is easy
- 18:01Speaker 8: for FoST understand so they can gain that trust. Because
- 18:04Speaker 8: you go to the doctor sometimes and they give you
- 18:06Speaker 8: this diagnosis and it's like a destiny. So how do
- 18:09Speaker 8: you help to provide hope by giving it in sizable
- 18:11Speaker 8: nuggets that you can understand and say there are therapies,
- 18:14Speaker 8: there are treatments out there that can help you.
- 18:16Speaker 5: That's so important.
- 18:17Speaker 3: And specialty pharmacy being able to be pushed out through
- 18:20Speaker 3: the platform that Walmart already has within their communities, and
- 18:24Speaker 3: then the pharmacists that are part of that, the most
- 18:26Speaker 3: trusted providers that we have. This is all making sense.
- 18:30Speaker 3: We're very proud of you and what you're doing. In
- 18:32Speaker 3: specially pharmacy. Thank you once again for spending time with
- 18:35Speaker 3: us here at the NASP's podcast review.
- 18:38Speaker 8: Thank you for having me and I hope you see
- 18:40Speaker 8: you again next year.
- 18:40Speaker 5: Oh yes, thank you, Aleida, You're welcome.
- 18:45Speaker 3: You are listening to the NASP podcast, part of the
- 18:49Speaker 3: Pharmacy Podcast Network. The delivery of medications from wherever they're
- 18:55Speaker 3: starting from, obviously are specialty pharmacies to the patient, and
- 19:00Speaker 3: how important temperature control is for specific compounds, and kind
- 19:05Speaker 3: of the scariness that we've talked about metrics around some
- 19:07Speaker 3: of the mail order systems out there that leave these
- 19:12Speaker 3: meds in the hot, burning sun or or hot mailboxes
- 19:15Speaker 3: and that sometimes can.
- 19:17Speaker 5: Be harmful to the medication.
- 19:19Speaker 3: I'm glad to have Orlando Videl here from Cold Chain
- 19:23Speaker 3: Technologies here at the NSP podcast.
- 19:26Speaker 5: Welcome Orlando.
- 19:27Speaker 10: Hey, you done, pleasure to be here.
- 19:29Speaker 3: All right, So tell me how are you helping to
- 19:32Speaker 3: serve a major issue in especially pharmacy, which is the
- 19:37Speaker 3: sensitivity of the components that makes up the actual medication,
- 19:41Speaker 3: and how you're stabilizing to assure that it gets to
- 19:44Speaker 3: the patient in the time that it needs to get
- 19:46Speaker 3: to the patient and staying within that temperature control.
- 19:49Speaker 10: Yeah, you know, I'd be happy to so, you know,
- 19:51Speaker 10: first I'd like to say it's not an issue. It's
- 19:54Speaker 10: a requirement by IRAQ, a AC and A drug manufacturers
- 19:57Speaker 10: and all pharmacists know. Yeah, there's a requirement for very
- 20:00Speaker 10: specific medication today. This take, for example, the GLP one
- 20:05Speaker 10: jugs will go viozmpic. Over seventy million people are expected
- 20:09Speaker 10: to be on this medication. High value drug ship to
- 20:13Speaker 10: your home. So the requirement is two to eight refrigerated
- 20:15Speaker 10: for now right for now. Soon to be tablets that
- 20:19Speaker 10: you know are a room temp that you can take,
- 20:21Speaker 10: but the majority of specialty medications, life sustaining medications require
- 20:25Speaker 10: some sort of room temperature. We have two to eight
- 20:27Speaker 10: celsius four fifteen to thirty or controlled room temperature. So
- 20:32Speaker 10: the critical part about specialty meds and temperature sensitive mads
- 20:35Speaker 10: is they can overheat for extended periods of time and
- 20:39Speaker 10: they can't freeze. You know, the medication freezes sometimes it's
- 20:44Speaker 10: surrendered binoculous. It just doesn't work anymore if it overheats
- 20:47Speaker 10: for certain periods of times. There's other side effects that
- 20:49Speaker 10: that impact that, you know, just going back to the
- 20:52Speaker 10: old pharmacy, days and I'm not a pharmacist. I'm an
- 20:54Speaker 10: electronic engineer and business major. But you know, amber bios
- 20:57Speaker 10: are there for a reason, right to keep sunlight out.
- 21:00Speaker 10: So these are all requirements of temperature requirements for these
- 21:03Speaker 10: medsine specialty pharmacy. The challenges are, hey, how do I
- 21:07Speaker 10: operate my specialty pharmacy, get reimbursements and contain my packaging costs?
- 21:13Speaker 10: Cold chain technology has been around for fifty years and
- 21:16Speaker 10: you know, when I was working in pharmacies, we'd get
- 21:18Speaker 10: insulated mail or throw a gel pack in it and
- 21:20Speaker 10: off we went up until the Joint Commission said hey,
- 21:22Speaker 10: what are you guys doing? And since then it's evolved
- 21:24Speaker 10: to IRAQ, act C, National Associates, specialty pharmacies and other
- 21:29Speaker 10: accreditation agencies that we're going to say, hey, well, you know,
- 21:32Speaker 10: we need to prove that these medications are lasting for
- 21:34Speaker 10: the duration of the ship. Then cold chain assists all
- 21:38Speaker 10: pharmacies that want to utilize cold chain products with training, testing,
- 21:44Speaker 10: qualified products, configurable products if they need that last anywhere
- 21:49Speaker 10: from twenty four hours to one hundred and twenty nine hours,
- 21:51Speaker 10: depending on a need. You know, being here at NASS,
- 21:54Speaker 10: it's pretty awesome because we get to showcase our products
- 21:57Speaker 10: and speak to people who have these problems or for
- 22:01Speaker 10: having issues. As you said, to meet the requirements for
- 22:04Speaker 10: your raging acc but more important, you know, to maintain
- 22:07Speaker 10: the integrity of the medication while it's being shopped.
- 22:10Speaker 3: All right, If you're listening to the show and you're
- 22:12Speaker 3: curious of how to work with Orlando and his team.
- 22:16Speaker 5: What's the best way to reach.
- 22:18Speaker 3: Out to your team and directing any of the listeners
- 22:21Speaker 3: to doing some business with you.
- 22:24Speaker 10: Sure at the Orlando Vidal and the email addresses oh VI,
- 22:29Speaker 10: I d A l at cold chaintech dot com and
- 22:33Speaker 10: I can be reached that area code six oh nine
- 22:36Speaker 10: seven four four eight six or just a bunch of
- 22:40Speaker 10: saying as Cold Chain Technologies will be the first company
- 22:42Speaker 10: that pops up.
- 22:43Speaker 5: Awesome. Thank you so much for participating in the ANSP podcast.
- 22:47Speaker 10: Thank you, it's a great time being here.
- 22:52Speaker 3: The pharmacyt Podcast network always loves being here. Shout out
- 22:55Speaker 3: to the NASP team of how wonderful this conference has
- 22:58Speaker 3: been a record setting attendance.
- 23:01Speaker 5: This has been amazing.
- 23:02Speaker 3: Part of our ecosystem that we desperately need is guidance
- 23:06Speaker 3: from our lawyers who really can zero down into issues
- 23:10Speaker 3: that could become obstacles or it could actually become issues
- 23:16Speaker 3: for specialty pharmacies. So Jeffrey fired. We really appreciate your guidance.
- 23:22Speaker 3: You were part of our NASP twenty twenty three post show,
- 23:25Speaker 3: and I wanted to welcome you back.
- 23:27Speaker 11: But Todd, it's nice to be back. It's our law firm.
- 23:31Speaker 11: We are very proud members of NASP. I'm co chair
- 23:35Speaker 11: of the Legal Committee, and we work closely with Sheila
- 23:40Speaker 11: and Arianna and everybody else. Now, you called me Jeffrey
- 23:43Speaker 11: only my mother called me Jeffrey, and that's when I
- 23:45Speaker 11: was in trouble, So you can call me jeff Yeah.
- 23:50Speaker 3: That my mother would say my middle name if I
- 23:52Speaker 3: was in trouble. So I always associate Steven with being
- 23:56Speaker 3: in trouble.
- 23:56Speaker 11: And I also I did a real good job of
- 24:00Speaker 11: ignoring your colleague over there.
- 24:01Speaker 5: She was taking my pictures.
- 24:04Speaker 3: Well, people listening to the podcast are probably in their
- 24:07Speaker 3: cars right now, or they're walking or something. The thing
- 24:10Speaker 3: that I wanted to bring to the tension for our
- 24:12Speaker 3: listeners is you talked today earlier here at the Nashville
- 24:18Speaker 3: Convention about.
- 24:20Speaker 5: The securityply chain.
- 24:22Speaker 9: Yes, right, So.
- 24:23Speaker 3: Let's get into that and give our listeners a survey
- 24:25Speaker 3: kind of a summary of what you were talking about.
- 24:27Speaker 11: Yeah, this is interesting stuff because you know, historically when
- 24:30Speaker 11: I have spoken here at the conference has been about
- 24:34Speaker 11: kickbacks and inducements and PBMs and things like that.
- 24:38Speaker 9: But what I and.
- 24:40Speaker 11: My partner Brad Howard I talked about today is the
- 24:44Speaker 11: Drug Supply Chain Security Act, otherwise it's known as the
- 24:48Speaker 11: SEA and this is really a big deal. This is
- 24:51Speaker 11: an outcrop of the New England Compounding Center tragedy in
- 24:56Speaker 11: twenty twelve, when sixty five people sixty four people.
- 25:00Speaker 9: Died of tainted compounded drugs.
- 25:04Speaker 11: Congress reacted and passed the Drug Quality Security Act, and
- 25:10Speaker 11: then underneath that several other pieces of legislation, one of
- 25:14Speaker 11: which is the DSCSA Drug Supply Chain Security Act. And
- 25:21Speaker 11: this has been in effect for about ten years. And
- 25:24Speaker 11: over the last ten years, manufacturers and the retailers and
- 25:27Speaker 11: wholesalers have had to comply with certain aspects of it.
- 25:32Speaker 11: But now it gets real because now pharmacies have to
- 25:36Speaker 11: and the law says that really actually a year ago
- 25:42Speaker 11: November of twenty twenty three, pharmacies and everybody else up
- 25:48Speaker 11: the food chain suppliers, soule sellers, distributors, manufacturers have to
- 25:54Speaker 11: have in place an electronic interoperable system that traces and
- 26:00Speaker 11: tracks the pedigree of a drug. So, in other words,
- 26:04Speaker 11: pharmacy hands a drug to mister smith.
- 26:07Speaker 9: You know, a bottle, you know what, box, whatever, that.
- 26:13Speaker 11: Pharmacy has to have information on hand that tracks whose
- 26:19Speaker 11: hands touched that drug all the way up to the manufacturer.
- 26:22Speaker 9: Is truly a track and trace the rash. Now, for
- 26:26Speaker 9: all this is.
- 26:27Speaker 11: To prevent illicit tainted drugs from entering the system.
- 26:34Speaker 5: Makes sense?
- 26:35Speaker 9: Now, I can keep talking, but you might have some
- 26:36Speaker 9: questions for me.
- 26:38Speaker 3: What I want to know is this felt like, not
- 26:42Speaker 3: only me as someone who is covering almost every aspect
- 26:47Speaker 3: a little bit of every aspect in our profession, it
- 26:50Speaker 3: seemed like it stalled and then they re told it
- 26:54Speaker 3: and now it's you know, getting its teeth back. So
- 26:57Speaker 3: what was the delay where they originally were launching it
- 27:00Speaker 3: sometime last year and they said, now it goes into
- 27:03Speaker 3: full effactory number.
- 27:04Speaker 11: Yeah, you've done, You've done your homework, Todd. And that
- 27:07Speaker 11: is the they're called the enhanced requirements, and that's where
- 27:14Speaker 11: beginning November twenty twenty three, all of the trading partners
- 27:20Speaker 11: in the drug supply chain, from the dispensers which that
- 27:23Speaker 11: are the pharmacies, all the way up to the manufacturers.
- 27:27Speaker 11: We're supposed to have in place a true track and
- 27:30Speaker 11: trace electronic system.
- 27:33Speaker 9: Well, at the end of the day, people weren't ready.
- 27:36Speaker 11: They just the the industry was not ready, and so
- 27:40Speaker 11: the FDA said, Okay, we're going to give you what's
- 27:43Speaker 11: called a stabilization period. In other words, we're going to
- 27:46Speaker 11: give you, guys, a one year break where you don't
- 27:49Speaker 11: have to you don't have to be ready to implement
- 27:52Speaker 11: all this now until November of twenty twenty four, and
- 27:56Speaker 11: that's where that's where we are now. But even now,
- 28:01Speaker 11: the drug supply chain is not ready for full implementation.
- 28:05Speaker 9: It's similar to odd to.
- 28:07Speaker 11: When, for example, with the Affordable Care Act or Obamacare,
- 28:12Speaker 11: the country legislation, insurance companies, Medicare, everybody else are still
- 28:19Speaker 11: trying to figure out how to implement Obamacare. It's a
- 28:23Speaker 11: process in fact that when it was past, President Obama said, hey,
- 28:27Speaker 11: this is this is just the beginning. Likewise, in healthcare,
- 28:31Speaker 11: we have what's called Hippa HIPAA, and that's been around
- 28:35Speaker 11: for good heavens fifteen twenty years and even now the industry.
- 28:41Speaker 9: Is trying to figure out how to fully implement hippo.
- 28:43Speaker 11: Well, the DSCSA is going to be a process, and
- 28:49Speaker 11: it's going to take a number of years for the
- 28:53Speaker 11: drug supply chain to truly be interoperable and work together
- 28:59Speaker 11: so that the degree of drugs can be traced all
- 29:02Speaker 11: the way to the very beginning. They'll be stops and stars,
- 29:05Speaker 11: there'll be successes, they'll be failures, they'll be frustrations.
- 29:09Speaker 9: The FDA is going to have.
- 29:11Speaker 11: To utilize this discretion in terms of enforcement, and still
- 29:16Speaker 11: we'll have and the state boards a pharmacy will have
- 29:19Speaker 11: as well.
- 29:19Speaker 9: So this is kind of a big deal.
- 29:22Speaker 5: Well, we appreciate the update.
- 29:24Speaker 3: It would be wonderful to have you and maybe someone
- 29:26Speaker 3: from the NASP that Sheila could find for us to
- 29:30Speaker 3: come on and tell us where we are in the
- 29:32Speaker 3: beginning of twenty twenty five. Love to and you're always
- 29:36Speaker 3: a wealth of information. So thank you Jeff for participating
- 29:38Speaker 3: in the NSP.
- 29:39Speaker 11: But Todd, thank you, and it's I'll participate time you
- 29:42Speaker 11: ask me.
- 29:42Speaker 3: It's always fun.
- 29:43Speaker 5: Thank you.
- 29:44Speaker 3: Thanks, Welcome to the Pharmacy Podcast. Networks coverage of the
- 29:51Speaker 3: NASP twenty twenty four. The ecosystem of specialty pharmacy is
- 29:56Speaker 3: not for the faint of heart. It's very complex, many
- 29:58Speaker 3: different healthcare providers coming through this. Our quarterback our physicians
- 30:02Speaker 3: who set the therapy in play, is handed off to
- 30:06Speaker 3: our specialty pharmacists and guess who else. Just like we
- 30:09Speaker 3: talked with Jennifer Noonan just last interview from Excessive Health,
- 30:13Speaker 3: our nurses are such a big part of this. I'd
- 30:15Speaker 3: like to introduce Sarah Allen, Director of Nursing and Jason Oakes,
- 30:20Speaker 3: director of Growth with Navean Health.
- 30:23Speaker 5: Welcome to the NEESP podcast.
- 30:25Speaker 3: Thank you all right, let's kick it off to Sarah
- 30:28Speaker 3: talk to us about navan Health and how and why
- 30:32Speaker 3: nurses are plugged into specialty pharmacy.
- 30:35Speaker 12: Okay, well, let me start with telling you what nave
- 30:37Speaker 12: and Health is. We're the first nationwide nursing network of
- 30:41Speaker 12: it's kind. We deliver infusion care to thousands of patients
- 30:45Speaker 12: in their home monthly. In their home being a keyword,
- 30:49Speaker 12: because that's where we're going in today's healthcare system. We
- 30:53Speaker 12: employ about what we employ over fifteen hundred nurses nationwide,
- 30:58Speaker 12: and we're growing at a rapid speed, and we provide
- 31:01Speaker 12: care in all fifty states. Today, we partner with over
- 31:04Speaker 12: one hundred specialty pharmacies, pharmaceutical manufacturers, and healthcare organizations.
- 31:10Speaker 3: Jason, what can we expect as let's pretend I'm a
- 31:14Speaker 3: specialty pharmacy, what can I expect working with NAVE and
- 31:17Speaker 3: Health when it's coming to that receiving that care that
- 31:20Speaker 3: I know that my patient's going to need in their
- 31:23Speaker 3: home when it comes to home in fusion.
- 31:25Speaker 13: Yeah, I appreciate that question. You know, I think what
- 31:28Speaker 13: we see a lot of times is, you know, the
- 31:31Speaker 13: old way of doing business is a pharmacy or a
- 31:33Speaker 13: health system would really need to partner with many local,
- 31:37Speaker 13: small nursing agencies. NAVAN is really trying to really do
- 31:41Speaker 13: business in a different way by being a national partner.
- 31:44Speaker 13: And so if you're a specialty pharmacy, you're likely nationwide
- 31:47Speaker 13: or at least regional, and when you're working with NAVAN,
- 31:51Speaker 13: you get that one corporation that's got a lot of
- 31:55Speaker 13: that continuity that you get with a nationwide partner. Right,
- 31:58Speaker 13: we have one way of doing intake. You get a
- 32:01Speaker 13: customer success manager, who is somebody who sits in a
- 32:04Speaker 13: clinical and an operational role. We do a customer newsletter,
- 32:09Speaker 13: we've got business intelligence and analytics. We do quarterly business
- 32:13Speaker 13: reviews with our customers. We hire about forty nurses a month,
- 32:17Speaker 13: we send out those new nurse alerts, right. So that's
- 32:20Speaker 13: the kind of thing that you can expect from a corporation, right,
- 32:23Speaker 13: a corporate corporate running, large size entity that NAVAN is.
- 32:29Speaker 13: But at the local level, you know, we are regionally distributed,
- 32:33Speaker 13: and we've got nurse management in the East, the West,
- 32:36Speaker 13: in the Central, and then we've got nurse managers by
- 32:38Speaker 13: state and staffing coordinators in those states, right, and our
- 32:42Speaker 13: nurses are obviously in the state, and so we're still
- 32:46Speaker 13: familiar with you know, the roads, the health systems, the cities,
- 32:51Speaker 13: the towns, the patients, and so you still are getting
- 32:54Speaker 13: that very local attention when it comes to the patient.
- 32:57Speaker 5: Care and the staffing.
- 32:58Speaker 13: And so we really prior to our being able to
- 33:01Speaker 13: work with really large partners in a very corporate field
- 33:04Speaker 13: that they expect and they're used to in equality in
- 33:07Speaker 13: a data perspective, but really deliver that one on one
- 33:10Speaker 13: patient care that you're still going to get at a
- 33:12Speaker 13: local level.
- 33:13Speaker 12: Yeah, and just to ping pong off, of him.
- 33:16Speaker 11: You know, our.
- 33:16Speaker 12: Network is so diverse with highly skilled nurses. It's not
- 33:22Speaker 12: just a nurse going into the home to provide care
- 33:26Speaker 12: to a patient. It is highly skilled nursing. We have
- 33:30Speaker 12: to know about these drugs. We have to support them
- 33:33Speaker 12: in that manner. A lot of these patients need patient
- 33:35Speaker 12: access programs and other things, so we're there to support
- 33:39Speaker 12: them in the comfort of their home while delivering exceptional care.
- 33:43Speaker 3: Jason, if someone's listening, I'm a specially pharmacy I want
- 33:46Speaker 3: to reach out to you.
- 33:47Speaker 5: What's the best way to get a hold of the
- 33:48Speaker 5: NAVE and team.
- 33:49Speaker 13: Yeah, I would go to navenhealth dot com. We have
- 33:51Speaker 13: a contact us link there and we'll get back to you,
- 33:55Speaker 13: you know, same day. It comes right to the growth
- 33:57Speaker 13: team and we're happy to kind of reach out and
- 34:00Speaker 13: talk to you.
- 34:01Speaker 8: Know.
- 34:01Speaker 13: What I do want to mention is we do gosh
- 34:04Speaker 13: somewhere over fourteen thousand home infusions a month. It's incredible
- 34:08Speaker 13: the amount that we're doing, and that's really in our
- 34:11Speaker 13: specialty pharmacy business, right, really delivering medications to folks in
- 34:16Speaker 13: their homes. We do a couple other things too, right
- 34:19Speaker 13: with our nursing network, we do a lot of work
- 34:21Speaker 13: directly with pharmaceutical manufacturers, really patient support programs, helping folks
- 34:27Speaker 13: become independent on some of those self injectible medications or
- 34:30Speaker 13: self infusible subcutaneous drugs. And so we do do quite
- 34:34Speaker 13: a bit of our business directly with pharmaceutical manufacturers and
- 34:37Speaker 13: really leverage that relationship with the specialty pharmacies with the
- 34:41Speaker 13: manufacturers through that programming. And then we actually support a
- 34:44Speaker 13: lot of decentralized clinical trials. And for us, what we're
- 34:47Speaker 13: really seeing, what really is at the core of an
- 34:50Speaker 13: even is two things really right. Giving folks the opportunity
- 34:54Speaker 13: to get access to care, whether that's infusions, patient support
- 35:00Speaker 13: through a farmer program, or even access to care through
- 35:02Speaker 13: a decentralized clinical trial that maybe they could never access before.
- 35:06Speaker 13: Through this nationwide nursing service, it's also an opportunity to
- 35:10Speaker 13: offer a different career option to nurses, right, And so
- 35:14Speaker 13: we're super proud of our nurses. We love our nurses.
- 35:17Speaker 13: That comes across in the quality and the retention of
- 35:20Speaker 13: our nurses and then the ability to bring on so
- 35:22Speaker 13: many nurses and provide that continuity of care and specialty.
- 35:26Speaker 13: What you'll find is a patient keeps that nurse. It's
- 35:29Speaker 13: very important for us to provide the same nurse over
- 35:31Speaker 13: and over again and build that long term relationship. And
- 35:34Speaker 13: we do that by being a great place to work
- 35:37Speaker 13: and offering a different type of work lifestyle to nurses nationwide.
- 35:42Speaker 5: And it's super.
- 35:43Speaker 13: Important to us, right. It's all about providing opportunity, whether
- 35:46Speaker 13: it's in healthcare or work to the folks that we're supporting,
- 35:50Speaker 13: both employees and patients.
- 35:52Speaker 12: Yeah, and speaking of quality, I mean, our patient satisfaction
- 35:55Speaker 12: scores are well above ninety five percent, so we do
- 36:00Speaker 12: really focused on that hands on patient care aspect of
- 36:03Speaker 12: the business and our nursing in the home.
- 36:08Speaker 3: Sarah Jason, thank you for being part of the NSP's
- 36:11Speaker 3: post show here in Nashville, and we hope to see
- 36:14Speaker 3: you in Denver next year.
- 36:15Speaker 13: Yeah, absolutely, thank you.
- 36:16Speaker 14: God.
- 36:21Speaker 3: Hey, this is a tradition for us at the Pharmacy
- 36:24Speaker 3: Podcast Network at the NASP twenty twenty four. Doctor Cecilia Buyers,
- 36:29Speaker 3: it's great to see you.
- 36:31Speaker 5: As well, Todd.
- 36:31Speaker 15: As always, I was watching you from across the little
- 36:35Speaker 15: hall here all week wondering like I need to get
- 36:38Speaker 15: in there and need to talk to Doud Number three.
- 36:40Speaker 5: This is the third NASP. We've talked, so it's exciting.
- 36:43Speaker 3: It is you've been pulled in so many directions, and
- 36:45Speaker 3: the reason is sure Scripts has positioned itself at a
- 36:49Speaker 3: whole other level now with the expansion of specialty pharmacy
- 36:53Speaker 3: and how much tech is coming at it and how
- 36:55Speaker 3: much data is coming at it. Talk to us about
- 36:58Speaker 3: what's happening with sure Scripts in your products and your
- 37:02Speaker 3: delivery and tech within specialty pharmacy.
- 37:05Speaker 15: Absolutely, yeah, we're starting to see expansion of our real
- 37:09Speaker 15: time prescription benefit really going into the pharmacy space. It
- 37:12Speaker 15: has been in retail for a while now, and just
- 37:14Speaker 15: trying to fine tune what does it need to do,
- 37:17Speaker 15: what does it need to what data needs to be
- 37:18Speaker 15: coming into it, working with partners to make sure that
- 37:21Speaker 15: we're able to support our pharmacy partners to the best
- 37:24Speaker 15: that we can with the data that's coming in. So
- 37:26Speaker 15: that's number one, right, and then we also have eligibility.
- 37:28Speaker 15: That's the core of everything a pharmacy needs is what
- 37:32Speaker 15: coverag does this patient have? So that's also a product
- 37:35Speaker 15: that many pharmacies have today. If you realize that you
- 37:38Speaker 15: can direct connect to share scripts or that same type
- 37:40Speaker 15: of information and have added features right, is it a
- 37:43Speaker 15: commercial plan, medicare, medicaid? Is this the primary, secondary, tertiary?
- 37:46Speaker 15: All of those things can be ordered and sent and
- 37:49Speaker 15: inform the pharmacy.
- 37:50Speaker 3: Is the best that we can What challenges are you
- 37:53Speaker 3: faced and that you say to the partners, that you
- 37:55Speaker 3: say to the specialty pharmacies, here's what we need so
- 37:58Speaker 3: that you can maximize the best the fit of what
- 38:00Speaker 3: sure Scripts is doing.
- 38:02Speaker 15: I think from the specialty pharmacy, it's just really you know,
- 38:05Speaker 15: what is your workflow? What are the things that you
- 38:06Speaker 15: need to be successful in your business? Because we recognize
- 38:09Speaker 15: that as a multi sided network, and what that means
- 38:12Speaker 15: is that we connect with providers, we connect with pharmacies,
- 38:14Speaker 15: we connect with PBMs and payers. What information do you
- 38:17Speaker 15: need and how then can we work together with other
- 38:21Speaker 15: areas of our network to be able to ensure that
- 38:22Speaker 15: we can try to get that information to you.
- 38:25Speaker 3: You have used the community pharmacy to kind of bang
- 38:31Speaker 3: up develop make sure that what is being used is
- 38:35Speaker 3: now moving to specialty. Is there any core products that
- 38:39Speaker 3: now you're realizing, Wow, this makes more sense in complex
- 38:43Speaker 3: disease management than it does in the community pharmacy space.
- 38:47Speaker 15: So we've had our specially medications Gateway live in specialty pharmacies,
- 38:51Speaker 15: and that was really where we I would say, had
- 38:53Speaker 15: the first really big start with specialty pharmacies. And that's
- 38:56Speaker 15: really getting data data from EHRs into the hands of
- 39:00Speaker 15: pharmacists and pharmacies to really better engage with the patient,
- 39:04Speaker 15: to be able to answer more questions upfront, and to
- 39:07Speaker 15: have a holistic picture of that patient.
- 39:08Speaker 9: That's really where we started.
- 39:10Speaker 15: We're actually seeing maybe a potential shift of that into
- 39:13Speaker 15: the retail side, so a lot of the other products,
- 39:15Speaker 15: it's you know, it's not necessarily a lift and move.
- 39:18Speaker 15: It's a lift. What more does it need? Fix those
- 39:21Speaker 15: things if we can and then move them over.
- 39:24Speaker 3: So there's a new podcast coming out from sure Scripts
- 39:28Speaker 3: on the Pharmacy podcast network that's going to continue to
- 39:32Speaker 3: define quality of networks. I can't remember the acronym q
- 39:37Speaker 3: hi u yes que yes. Talk to us about that
- 39:41Speaker 3: because that's really exciting.
- 39:42Speaker 15: Yeah, So that's like next level interoperability. What's interesting is
- 39:46Speaker 15: I know a few a few podcasts to go. Interoperability
- 39:49Speaker 15: was that was that was our key term, right, and
- 39:52Speaker 15: really what that does is that really helps to further
- 39:55Speaker 15: connect and be able to not only receive data, but
- 40:00Speaker 15: pharmacies to be able to put data out into healthcare ecosystem.
- 40:03Speaker 15: So today with the Specially Medications Gateway, it's just a
- 40:05Speaker 15: one way pharmacies request and they get the information they
- 40:09Speaker 15: need to be able to do their work. QHIN under TEFKA.
- 40:12Speaker 15: So the Trusted Exchange Framework in Common Agreement has this
- 40:16Speaker 15: q HEN so Qualified Health Information Network, and what they
- 40:20Speaker 15: do that QHN is it connects to all the different stakeholders,
- 40:24Speaker 15: so providers, pbmsr EHRs, further down to providers, pharmacy, technology vendors,
- 40:30Speaker 15: down to the pharmacy even to the patient to be
- 40:34Speaker 15: able to connect all of those dots. So when one
- 40:36Speaker 15: of those stakeholders requests information, it goes back up to
- 40:40Speaker 15: the QHEN, The q HEN federates that request down those
- 40:43Speaker 15: people that know this patient then send the information back
- 40:46Speaker 15: up and down through so it's really kind of back
- 40:49Speaker 15: and forth. It's bi directional sharing and receiving of information.
- 40:53Speaker 15: But there's not just one q hen, right that would
- 40:55Speaker 15: make things way too easy, So there will be multiple
- 40:58Speaker 15: So one qhan will talk to another q hen, We'll
- 41:00Speaker 15: talk to another q hin talk to another q hen,
- 41:03Speaker 15: all under the umbrella of TEFKA. So what it will
- 41:07Speaker 15: allow is where today we have many health exchanges. I
- 41:10Speaker 15: don't know if you know the number. I don't even
- 41:12Speaker 15: know the number that there are to be exact, but
- 41:15Speaker 15: there are multiple health exchanges that exist that don't necessarily
- 41:18Speaker 15: talk to each other today. This will allow all of
- 41:20Speaker 15: those networks to connect and talk to each other. So
- 41:24Speaker 15: we're ensured that if a patient lives in New York
- 41:26Speaker 15: but is a visiting family in California, they can probably
- 41:29Speaker 15: see the data, the information from those health systems of
- 41:32Speaker 15: information in New York, which is great.
- 41:34Speaker 3: Cecilia, It's always a pleasure to catch up with you
- 41:37Speaker 3: at the NASP. Can't wait to see you in Denver,
- 41:41Speaker 3: Colorado next year to twenty twenty five.
- 41:44Speaker 15: Super excited for Denver.
- 41:45Speaker 5: Yes, thank you, Thanks Tott.
- 41:47Speaker 3: As always Cratio scientia.
- 41:54Speaker 5: Sure is that the way to say it?
- 41:56Speaker 14: Well, absolutely it is. You know, this is Latin for
- 42:01Speaker 14: the creation of knowledge, and that's what we're all about.
- 42:05Speaker 16: We founded the company John Hammrick and I with the
- 42:08Speaker 16: intention of combining our experience in our background and the
- 42:14Speaker 16: folks that we've met over the years, and really to
- 42:17Speaker 16: bring an independent voice to put together solutions to connect
- 42:23Speaker 16: the innovation that is in the pharmasical pipeline with.
- 42:26Speaker 5: The patients that need it.
- 42:27Speaker 14: So we're super excited to talk to you and super
- 42:30Speaker 14: excited to be here at an ASP show.
- 42:33Speaker 3: You're like the godmother of specialty pharmacy consulting, so we're
- 42:37Speaker 3: really excited to have you on the NSP podcast here
- 42:40Speaker 3: at the annual event.
- 42:41Speaker 5: John, Welcome to the show. That's great to be here.
- 42:44Speaker 3: Thanks Ton. All right, so I want to know what
- 42:48Speaker 3: you're doing in this next phase of your career.
- 42:51Speaker 5: John.
- 42:51Speaker 3: We could actually have a ten part series on your
- 42:54Speaker 3: career and specialty pharmacy, but I want to know specifically
- 42:58Speaker 3: what now is taking place that CRATIO has now caught fire.
- 43:03Speaker 17: Yeah. I mean it's really a function of where we
- 43:06Speaker 17: are from a technology standpoint in space. If you think
- 43:09Speaker 17: about basically every meeting, including this one, everybody's trying to
- 43:12Speaker 17: get their heads wrapped around AI as well as what
- 43:15Speaker 17: technology enabled patient engagement really means. And look like I
- 43:19Speaker 17: think from our perspective, there's you know, sort of the
- 43:23Speaker 17: idea of operational, frontical and financial excellence is what every
- 43:27Speaker 17: organization is trying to pursue. And I would say that's
- 43:30Speaker 17: kind of what we are doing as a consulting practice.
- 43:33Speaker 17: As Cheryl said, we benefit from, you know, a few
- 43:37Speaker 17: years in the industry, but also a network of phenomenal
- 43:40Speaker 17: people and expertise who've sort of seen the film before,
- 43:43Speaker 17: but are also the innovators. I think we brought together
- 43:46Speaker 17: a team of people who literally were some of the
- 43:48Speaker 17: pioneers in the industry. So while they have experience, they
- 43:52Speaker 17: also have the ability to be super innovative and figure
- 43:55Speaker 17: out how do we best moved in the next phase
- 43:58Speaker 17: of better pay engagement, better outcomes.
- 44:02Speaker 5: Cheryl, So, I understand the hubs.
- 44:06Speaker 3: I understand the manufacturers how they're very choosy about which
- 44:10Speaker 3: specialty pharmacies they're working with. I understand our wholesalers and
- 44:14Speaker 3: the Technology Platforms Assembly as a wonderful organization. They're here
- 44:19Speaker 3: at the NESP obviously, but it's the consultant that you
- 44:22Speaker 3: can get down into the weeds with the specialty pharmacy
- 44:26Speaker 3: to really tune in what their sweet spot is versus
- 44:29Speaker 3: another specialty pharmacy. Talk to us about how you're actually
- 44:34Speaker 3: helping specialty pharmacies find that sweet spot.
- 44:37Speaker 14: Yeah, one hundred percent.
- 44:39Speaker 16: You know from where we come from, you know, John
- 44:41Speaker 16: and I both have backgrounds in specialty pharmacy and.
- 44:45Speaker 14: It's pre to who we are. It's it is that
- 44:49Speaker 14: patient engagement, and what we effort to do in this
- 44:52Speaker 14: special two pharmacy space is to help them to best
- 44:56Speaker 14: understand how they are viewed through the len of the
- 45:00Speaker 14: pharmaceutical manufacturer. When a manufacturer goes.
- 45:04Speaker 18: To into the channel and looks to the specialty space,
- 45:08Speaker 18: particularly in limited distribution, very limited which could be you know, one, two.
- 45:15Speaker 14: Three, or four special two pharmacies.
- 45:17Speaker 18: You know, what are those unique differentiators.
- 45:22Speaker 14: We have so many wonderful specialty pharmacies with such amazing
- 45:27Speaker 14: skill sets.
- 45:28Speaker 16: What we have the.
- 45:29Speaker 14: Pharmacies to do is to really highlight their differentiators. Now
- 45:33Speaker 14: this could be within their clinical expertise around therapy categories.
- 45:39Speaker 14: So we have some pharmacies that index very highly in
- 45:42Speaker 14: such areas as rare disease, so you've got the Panther,
- 45:46Speaker 14: you've got Orsini and rare disease and others. Also a
- 45:50Speaker 14: Novo a very unique model exclusive, right, so they're totally
- 45:56Speaker 14: one stop shop for pharmastical manufacturer. Then includes the three ball,
- 46:00Speaker 14: and then we go further, you know, and we look
- 46:03Speaker 14: at gosh, there's oncology, like you is helping to support
- 46:06Speaker 14: those patients there biologics you got on for through sixty.
- 46:10Speaker 16: So it really is looking within those spaces to see, like.
- 46:14Speaker 14: How do you engage There are other therapeutic areas which
- 46:18Speaker 14: you know, we probably weren't thinking of, but now you
- 46:21Speaker 14: think about transports because you have you know, like Lifeline
- 46:24Speaker 14: and some of the others where wow, it's interesting to
- 46:29Speaker 14: begin to look at those areas of expertise and help
- 46:33Speaker 14: the manufacturers to understand those partners.
- 46:35Speaker 5: In that way.
- 46:37Speaker 3: John, I think of our independently owned specialty pharmacies.
- 46:42Speaker 5: I think of the.
- 46:42Speaker 3: Consultants obviously, not that not your consultant type, but the
- 46:47Speaker 3: consultant that goes and like actually meets with certain patients
- 46:49Speaker 3: and consults with the patient. But that's the health system
- 46:53Speaker 3: specially pharmacy that seems on the rise. Is there a
- 46:56Speaker 3: sweet spot with your consultancy that you're helping a blend
- 46:59Speaker 3: of a health.
- 47:00Speaker 5: System, hospital system.
- 47:01Speaker 3: Specialty pharmacy versus the standalone.
- 47:04Speaker 17: Yeah, I mean, I think one of the things that
- 47:07Speaker 17: Cheryl and I really felt was important as we really
- 47:10Speaker 17: decided to found the business, was to leverage our experience
- 47:15Speaker 17: in the industry to figure out how to create better
- 47:20Speaker 17: access and better outcomes for patients. And you know, in
- 47:24Speaker 17: our logo we sort of have there's a reference, if
- 47:27Speaker 17: you will, to the five p's. We think of it
- 47:30Speaker 17: as the provider, the payer, the patient, the product flow
- 47:34Speaker 17: obviously and attributes on the payer. So when you talk
- 47:37Speaker 17: about the independent specialty pharmacy, or the health system specialty
- 47:41Speaker 17: pharmacy or the payer PVM own specialty pharmacy, you know,
- 47:45Speaker 17: there's a lot of players in the space. And really
- 47:48Speaker 17: what we see our role in the what we think
- 47:50Speaker 17: of the specialty health care space in general, is to
- 47:53Speaker 17: facilitate better collaboration engagement for all these parties, whether it's
- 47:57Speaker 17: the health services providers or the the pharmaceutical manufacturers, who.
- 48:01Speaker 5: Are trying to get.
- 48:04Speaker 17: The best patient journey okay, meaning how do we mitigate
- 48:08Speaker 17: those pain points that a patient's likely to face, where
- 48:10Speaker 17: the provider is going to face when they're trying to
- 48:12Speaker 17: get a patient on the therapy all the way through
- 48:14Speaker 17: that patient journey. In the case of the health system,
- 48:17Speaker 17: they have amazing capabilities to integrate all the insights that
- 48:20Speaker 17: they have from the EMR and the connectivity to the
- 48:22Speaker 17: provider with their specialty pharmacy service and through that integration
- 48:27Speaker 17: of those activities ultimately wrap that patient in their entirety.
- 48:31Speaker 17: And so that's really what is the biggest differentiator that
- 48:36Speaker 17: I think the health system would.
- 48:39Speaker 5: Claim with their specialty pharmacies.
- 48:41Speaker 17: But every provider in the space has challenges that they
- 48:43Speaker 17: have to deal with, whether it be access to certain
- 48:46Speaker 17: drugs or you know, the resources within the organization to
- 48:50Speaker 17: be aligned to those those things that patients need. So
- 48:55Speaker 17: I think that's what we're really helping in the health
- 48:57Speaker 17: system specially pharmacy space for example, going on right now,
- 49:01Speaker 17: and it's been a challenge for a while, and there's
- 49:03Speaker 17: a number of data aggregators that are trying to say, hey,
- 49:06Speaker 17: we can provide the data and collect the data that
- 49:10Speaker 17: say payer or pharmaceutical manufacturers that are looking for and
- 49:14Speaker 17: the same type of data they would typically see from
- 49:17Speaker 17: the poor traditional members of their specialty pharmacy networks. But
- 49:23Speaker 17: there's various reasons why that's more challenging for them to get.
- 49:28Speaker 17: So that's sort of an area that we're really spending
- 49:29Speaker 17: a lot of time on right now for what's the
- 49:33Speaker 17: best model for say, for example, an oncology product that
- 49:38Speaker 17: is going to be supported by a certain number of
- 49:40Speaker 17: traditional specialty pharmacies that has a lot of health system
- 49:44Speaker 17: sp exposure and that frankly in the community oncologies practice setting,
- 49:49Speaker 17: whether there's in office dispensing or specially pharmacy capabilities, there
- 49:55Speaker 17: is a heterogeneous space in terms of the kinds of
- 49:59Speaker 17: data you're going to get from each of those segments.
- 50:01Speaker 5: It's a problem right now, and that's the type of.
- 50:03Speaker 17: Thing we're kind of solved for with our clients, whether
- 50:06Speaker 17: they be the providers themselves, the especially pharmacies are the manufacturers.
- 50:11Speaker 3: Cheryl and John, I've really appreciated this time with.
- 50:15Speaker 5: You at the NASP.
- 50:16Speaker 3: I appreciate that curatio is rising and helping other specialty
- 50:20Speaker 3: pharmacies really strengthen themselves so that we can serve patients
- 50:24Speaker 3: better and in closing, what's the best way to reach
- 50:27Speaker 3: out to you, Cheryl, in order to engage and possibly
- 50:30Speaker 3: get the assistance that a lot of specialty pharmacies are
- 50:33Speaker 3: looking for.
- 50:34Speaker 14: Absolutely, thank you for the opportunity, and we appreciate what
- 50:37Speaker 14: you're doing in this space to really advocate on behalf
- 50:41Speaker 14: of specialty pharmacy and really to advocate and we have
- 50:46Speaker 14: the patients and access to your therapy.
- 50:49Speaker 19: So you can reach out to us through our website,
- 50:54Speaker 19: you Reachhare Advisors dot com and or reach out to
- 50:58Speaker 19: me personally or John person.
- 51:00Speaker 5: And we look forward to talking to you.
- 51:03Speaker 14: And again you know, it's all within the scope of
- 51:07Speaker 14: being the best advocates that we can on behalf of
- 51:10Speaker 14: those patients to get the drug products that they have.
- 51:14Speaker 5: Cheryl John, thank you so much.
- 51:16Speaker 17: Hey Todd, thank you so much. You are the OG
- 51:18Speaker 17: podcast and the pharmacy Pody spot Fither It's the bomb.
- 51:22Speaker 5: There you go, the pod Father.
- 51:24Speaker 17: Thanks the Podfather.